These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 6849515)

  • 21. [Criteria for discontinuation of sustained-release theophylline in children with chronic asthma].
    Battistini A; Grzincich GL; Ferrara D
    Pediatr Med Chir; 1986; 8(5):665-9. PubMed ID: 3601697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Continuous treatment of asthma in children with theophylline retard].
    de Blic J; Scheinmann P; Benoist MR; Ruff F; Paupe J
    Arch Fr Pediatr; 1983 Feb; 40(2):123-7. PubMed ID: 6870478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM; Weinstein DB; Watts MT; Seifert B
    Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical effectiveness of a new preparation of sustained-release theophylline].
    Corrias A; Pelosi U; Corona GB; Burrai P; Corda R
    Pediatr Med Chir; 1989; 11(5):537-9. PubMed ID: 2631061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of long-term oral administration of a sustained release theophylline preparation in children with chronic asthma.
    Cantani A; Businco E; Businco L; Solano A; Calabretta C
    Allergol Immunopathol (Madr); 1983; 11(1):11-4. PubMed ID: 6858803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pulmonary volume and flows in asthmatic children in therapy with prompt and delayed-action theophylline: preliminary report].
    Fiocchi A; Berardinelli P; Di Donna C; Arensi D; Riva E
    Pediatr Med Chir; 1984; 6(5):641-4. PubMed ID: 6535125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise, induced bronchospasm in asthmatic children as a dose-response model for theophylline.
    Bierman CW; Shapiro GG; Pierson WE; Cho YW
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):245-8. PubMed ID: 669869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid and sustained oral theophylline loading. An alternative to intravenous aminophylline therapy.
    Brown DL; Maddux MS; Organek HW; Bauman JL
    Arch Intern Med; 1983 Apr; 143(4):794-6. PubMed ID: 6838301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The evaluation parameters of the long-term treatment efficacy of theophylline in the child with bronchial asthma].
    Panta P; Nanulescu MV; Palibroda N; Culea M
    Pneumoftiziologia; 1997; 46(4):257-62. PubMed ID: 9654966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sustained-action oral theophylline in the asthmatic child. Clinical, pharmacokinetic and respiratory function studies].
    Baculard A; Morgant G; Gaultier C; Boule M; Tournier G
    Rev Fr Mal Respir; 1983; 11(6):833-46. PubMed ID: 6669796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients.
    Adachi M; Aizawa H; Ishihara K; Ohta K; Sano Y; Taniguchi H; Nakashima M
    Respir Med; 2008 Jul; 102(7):1055-64. PubMed ID: 18394875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum theophylline concentrations are not affected by coadministration of doxycycline.
    Seggev JS; Shefi M; Schey G; Farfel Z
    Ann Allergy; 1986 Feb; 56(2):156-7. PubMed ID: 3946849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of slow-release theophylline on airway inflammation in bronchial asthma].
    Adachi M; Minoguchi K; Mita S; Kokubu F; Suzuki H; Sano Y; Akiyama K; Yasuhara H
    Arerugi; 1998 Aug; 47(8):734-43. PubMed ID: 9796114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new sustained-release theophylline suspension for asthmatic children: evaluation of serum theophylline concentrations.
    Boner AL; Vallone G; Valletta E; Bernocchi D; Plebani M
    Int J Clin Pharmacol Res; 1987; 7(5):345-50. PubMed ID: 3667007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apparent decrease in population clearance of theophylline: implications for dosage.
    Asmus MJ; Weinberger MM; Milavetz G; Marshik P; Teresi ME; Hendeles L
    Clin Pharmacol Ther; 1997 Nov; 62(5):483-9. PubMed ID: 9390104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
    Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
    Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metaproterenol and theophylline in asthmatic children.
    Rachelefsky GS; Katz RM; Mickey MR; Siegel SC
    Ann Allergy; 1980 Oct; 45(4):207-12. PubMed ID: 7425389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic properties of sustained-release theophylline (Theolair-SR) in relation to timing of doses after low-fat meals.
    Welsh PW; O'Connell EJ; Sachs MI; Moyer TP; Wick KA; Harrison LI; McCarville SE; Kvam DC
    Ann Allergy; 1989 May; 62(5):396-400. PubMed ID: 2719348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A sustained release theophylline preparation: efficacy in childhood asthma with low serum theophylline levels.
    Rachelefsky GS; Katz RM; Siegel SC
    Ann Allergy; 1978 Apr; 40(4):252-7. PubMed ID: 345889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between pharmacodynamics and pharmacokinetics in asthmatic children receiving a sustained-release formulation of theophylline.
    Schaefers M; Richter O; Reinhardt D; Becker B
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):406-15. PubMed ID: 6490223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.